Baillie Gifford & Co’s 908 Devices MASS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-249
Closed -$2.14K 384
2023
Q1
$2.14K Hold
249
﹤0.01% 436
2022
Q4
$1.9K Hold
249
﹤0.01% 469
2022
Q3
$4K Hold
249
﹤0.01% 454
2022
Q2
$5K Hold
249
﹤0.01% 451
2022
Q1
$5K Hold
249
﹤0.01% 467
2021
Q4
$6K Hold
249
﹤0.01% 474
2021
Q3
$8K Hold
249
﹤0.01% 464
2021
Q2
$10K Buy
+249
New +$11.3K ﹤0.01% 435

Other funds holding MASS

Baillie Gifford & Co's MASS Position: Q2 2023 in Review

Baillie Gifford & Co sold out of 908 Devices (MASS) in Q2 2023, closing a stake of 249 shares — an estimated $2.14K sold.

Baillie Gifford & Co first reported a position in MASS in Q2 2021 and held it in 8 quarters. The position peaked at $10K in Q2 2021. 85 funds tracked by Wall St. Rank hold MASS as of Q2 2023.

  • Baillie Gifford & Co reported no remaining 908 Devices position as of Q2 2023 after selling out during the quarter.
  • Baillie Gifford & Co sold 249 908 Devices shares in Q2 2023, an estimated $2.14K.
  • Baillie Gifford & Co first reported a position in 908 Devices in Q2 2021 and held it in 8 quarters.
  • Baillie Gifford & Co's 908 Devices position peaked at $10K in Q2 2021.
  • 85 funds tracked by Wall St. Rank held 908 Devices as of Q2 2023.

Based on Baillie Gifford & Co's 13F filing for Q2 2023, filed 28 Jul 2023.